INDP · Categories · Form 4

INDP - SEC Form 4 insider transactions

Indaptus Therapeutics Inc. (INDP) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for INDP

• 76d
  SEC Form 4 filed by Lazar David E.

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 101d
  SEC Form 4 filed by Director Jabbour Jerome D

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 115d
  SEC Form 4 filed by Co-Chief Executive Officer Meckler Jeffrey A

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 137d
  Director Ben-Tzvi Avraham was granted 25,000 shares, increasing direct ownership by 25,000% to 25,100 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 137d
  SEC Form 4 filed by Director Natan David

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 161d
  Chief Operating Officer Linscott Walt Addison was granted 54,421 shares, increasing direct ownership by 1,088,420% to 54,426 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 161d
  Co-Chief Executive Officer Meckler Jeffrey A was granted 216,617 shares, increasing direct ownership by 1,627% to 229,929 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 161d
  Chief Financial Officer Sassi Nir was granted 26,758 shares (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 161d
  CSO and Director Newman Michael James was granted 52,204 shares, increasing direct ownership by 107% to 101,074 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 314d
  Chief Executive Officer Meckler Jeffrey A was granted 6,068 shares, increasing direct ownership by 84% to 13,312 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 362d
  SEC Form 4 filed by Director Karah Hila

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 362d
  SEC Form 4 filed by Director Martell Robert

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 362d
  SEC Form 4 filed by Director Pomerantz Roger

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 362d
  SEC Form 4 filed by Director Hayes William B

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 362d
  SEC Form 4 filed by Director Maddaluna Anthony J

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 362d
  SEC Form 4 filed by Director Gilbert Mark John

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 559d
  CEO and Director Meckler Jeffrey A was granted 42,553 shares, increasing direct ownership by 27% to 202,859 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 606d
  SEC Form 4 filed by CEO and Director Meckler Jeffrey A

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 606d
  SEC Form 4 filed by Chief Operating Officer Linscott Walt Addison

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 606d
  SEC Form 4 filed by CSO and Director Newman Michael James

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 606d
  SEC Form 4 filed by Chief Medical Officer Waltzman Roger J.

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 606d
  SEC Form 4 filed by Chief Financial Officer Sassi Nir

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 669d
  CEO and Director Meckler Jeffrey A was granted 84,932 shares, increasing direct ownership by 113% to 160,306 units (SEC Form 4)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 731d
  SEC Form 4 filed by Pomerantz Roger

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 731d
  SEC Form 4 filed by Karah Hila

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 731d
  SEC Form 4 filed by Maddaluna Anthony J

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 731d
  SEC Form 4 filed by Gilbert Mark John

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 731d
  SEC Form 4 filed by Martell Robert

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 731d
  SEC Form 4 filed by Hayes William B

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 867d
  SEC Form 4 filed by Newman Michael James

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 867d
  SEC Form 4 filed by Waltzman Roger J.

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 867d
  SEC Form 4 filed by Linscott Walt Addison

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 867d
  SEC Form 4 filed by Meckler Jeffrey A

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 867d
  SEC Form 4 filed by Sassi Nir

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1027d
  SEC Form 4: Anderson Glen R. bought $216,388 worth of shares (103,352 units at $2.09)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1036d
  SEC Form 4 filed by Waltzman Roger J.

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1105d
  SEC Form 4 filed by Karah Hila

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1105d
  SEC Form 4 filed by Hayes William B

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1105d
  SEC Form 4 filed by Gilbert Mark John

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1105d
  SEC Form 4 filed by Pomerantz Roger

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1105d
  SEC Form 4 filed by Maddaluna Anthony J

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1210d
  SEC Form 4 filed by Martell Robert

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1235d
  SEC Form 4 filed by Linscott Walt Addison

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1235d
  SEC Form 4 filed by Meckler Jeffrey A

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1235d
  SEC Form 4 filed by Newman Michael James

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1235d
  SEC Form 4 filed by Sassi Nir

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1267d
  SEC Form 4: Litchev Boyan Vesselinov bought $2,520 worth of shares (1,150 units at $2.19)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1295d
  SEC Form 4: Meckler Jeffrey A bought $18,945 worth of shares (10,000 units at $1.89), increasing direct ownership by 15% to 75,374 units

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1344d
  SEC Form 4 filed by Karah Hila

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1344d
  SEC Form 4 filed by Pomerantz Roger

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1344d
  SEC Form 4 filed by Hayes William B

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1344d
  SEC Form 4 filed by Maddaluna Anthony J

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1344d
  SEC Form 4 filed by O'Callaghan Brian

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1344d
  SEC Form 4 filed by Gilbert Mark John

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1366d
  SEC Form 4: Meckler Jeffrey A bought $28,862 worth of shares (10,308 units at $2.80), increasing direct ownership by 19% to 65,374 units

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1369d
  SEC Form 4: Linscott Walt Addison bought $393 worth of shares (150 units at $2.62)

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1370d
  SEC Form 4: Meckler Jeffrey A bought $24,771 worth of shares (9,692 units at $2.56), increasing direct ownership by 21% to 55,066 units

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1463d
  SEC Form 4: Meckler Jeffrey A bought $51,882 worth of shares (19,727 units at $2.63), increasing direct ownership by 77% to 45,374 units

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1587d
  SEC Form 4 filed by Litchev Boyan Vesselinov

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)
• 1587d
  SEC Form 4: Newman Michael James sold $100,043 worth of shares (20,000 units at $5.00) as part of a pre-agreed trading plan

  4 - Indaptus Therapeutics, Inc. (0001857044) (Issuer)

Other INDP categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends